Getting your Trinity Audio player ready...
“The chance that it becomes a product is not zero, but it’s hard to calculate and justify how much above zero it is.”
— David Stone, a Cowen & Co. analyst, after Protein Design Labs Inc. said that a clinical trial of its lead drug to treat a potentially blinding AIDS-related infection was halted after it was found that more patients taking the drug were dying than those taking a placebo.
